SANA Sana Biotechnology, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 10, 2026
$2,89
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$2,6152-Wochen-Tief
$6,5552-Wochen-Hoch
Marktkapitalisierung (MRQ)
$865M
P/E
-3.0
EPS
$-0.96
Ihre Abzeichen
52W-Spanne
$3–$7
Analystenbewertung
BUY
Kursziel
$8
P/E
-3.0
ROE
-172.3%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
SANA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.89
Marktkapitalisierung (MRQ)
$865M
P/E
-3.0
EPS
$-0.96
ROE
-172.3%
52W-Spanne
$3–$7
SANA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über Sana Biotechnology, Inc. - Common Stock Unternehmensübersicht von Wikipedia
SektorHealthcare
BrancheBiotechnology
Mitarbeiter142
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
EPS$-0.962020-12-31 → 2025-12-31
Freier Cashflow$-145M2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | SANA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -3.05-Jahres-Durchschnitt ≈-3.7 | ≈-3.7 | · | · | |
| K/B (MRQ) | 5.65-Jahres-Durchschnitt ≈3.3 | ≈3.3 | 4.7 | Überbewertet | |
| Kurs / FCF (TTM) | -6.45-Jahres-Durchschnitt ≈-4.9 | ≈-4.9 | · | · | |
| Kurs / Cashflow (TTM) | -6.55-Jahres-Durchschnitt ≈-5.3 | ≈-5.3 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 9.15-Jahres-Durchschnitt ≈6.1 | ≈6.1 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | SANA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -53.2%5-Jahres-Durchschnitt ≈-42.0% | ≈-42.0% | -35.0% | Schwach | |
| ROE | -172.3%5-Jahres-Durchschnitt ≈-90.7% | ≈-90.7% | -50.7% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | SANA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 1.45-Jahres-Durchschnitt ≈3.7 | ≈3.7 | 6.4 | Geringe Liquidität | |
| Quick Ratio | 1.85-Jahres-Durchschnitt ≈3.5 | ≈3.5 | 4.6 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-12.9%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 10, 2026 | $-0.22 | $-0.15 | -47.9% |
| 31. März 2026 | Mai 13, 2026 | $-0.17 | $-0.17 | 1.7% |
| 31. Dezember 2025 | $-0.21 | $-0.14 | -55.0% | |
| 30. September 2025 | $-0.16 | $-0.18 | 12.8% | |
| 30. Juni 2025 | $-0.21 | $-0.21 | 0.47% | |
| 31. März 2025 | $-0.21 | $-0.23 | 10.3% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $132M | $216M | $262M | $286M | $249M | $133M | |
| SG&A Expense | $44M | $64M | $73M | $72M | $50M | $28M | |
| Operating Expenses | $250M | $273M | $293M | $273M | $357M | $286M | |
| Operating Income | $-250M | $-273M | $-293M | $-273M | $-357M | $-286M | |
| Other Non-op | $2M | $-5M | $-52.0K | $-674.0K | $305.0K | $97.0K | |
| Pretax Income | · | · | · | · | $-356M | $-285M | |
| Income Tax | $0 | · | · | · | · | · | |
| Net Income | $-244M | $-267M | $-283M | $-269M | $-356M | $-285M | |
| EPS (Basic) | $-0.96 | $-1.16 | $-1.46 | $-1.43 | $-2.14 | $-21.92 | |
| EPS (Diluted) | $-0.96 | $-1.16 | $-1.46 | $-1.43 | $-2.14 | $-21.92 | |
| Shares (Basic) | 253,234,000 | 230,891,000 | 194,541,000 | 188,344,000 | 166,433,000 | 13,014,000 | |
| Shares (Diluted) | 253,234,000 | 230,891,000 | 194,541,000 | 188,344,000 | 166,433,000 | 13,014,000 | |
| EBITDA | $-250M | $-273M | $-293M | $-273M | $-357M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $72M | $128M | $134M | $177M | $253M | $125M | |
| Short-term Investments | $67M | $25M | $72M | $247M | $298M | $253M | |
| Prepaid Expense | $6M | $4M | $4M | $14M | $7M | $6M | |
| Current Assets | $149M | $161M | $214M | $444M | $558M | $384M | |
| PP&E (Net) | $27M | $77M | $71M | $67M | $65M | $47M | |
| PP&E (Gross) | $82M | $131M | $112M | $101M | $84M | $55M | |
| Accum. Depreciation | $55M | $54M | $42M | $34M | $19M | $8M | |
| Goodwill | $141M | $141M | $141M | $141M | $141M | $141M | |
| Intangibles | $59M | $59M | $59M | $59M | $59M | $59M | |
| Other Non-current Assets | $3M | $5M | $6M | $5M | $5M | $190.0K | |
| Total Assets | $417M | $501M | $565M | $823M | $1.13B | $730M | |
| Accounts Payable | $2M | $5M | $4M | $3M | $2M | $2M | |
| Current Liabilities | $79M | $45M | $64M | $112M | $99M | $31M | |
| Capital Leases | $64M | $82M | $91M | $96M | $102M | $68M | |
| Other Non-current Liabilities | $11M | $10M | · | · | · | $540.0K | |
| Total Liabilities | $256M | $251M | $278M | $323M | $401M | $299M | |
| Common Stock | $27.0K | $22.0K | $20.0K | $19.0K | $18.0K | $2.0K | |
| Paid-in Capital | $2.01B | $1.86B | $1.63B | $1.56B | $1.52B | $8M | |
| Retained Earnings | $-1.85B | $-1.60B | $-1.34B | $-1.05B | $-785M | $-429M | |
| AOCI | $28.0K | $14.0K | $-60.0K | $-4M | $-1M | $30.0K | |
| Stockholders' Equity | $161M | $251M | $288M | $499M | $729M | $-421M | |
| Liabilities + Equity | $417M | $501M | $565M | $823M | $1.13B | $730M | |
| Shares Outstanding | 266,732,000 | 223,923,000 | 197,857,000 | 191,022,000 | 184,929,000 | 16,170,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $25M | $38M | $36M | $38M | $22M | $6M | |
| Amort. of Intangibles | $0 | $0 | $0 | $0 | $0 | · | |
| Operating Cash Flow | $-144M | $-223M | $-254M | $-290M | $-251M | $-138M | |
| CapEx | $938.0K | $33M | $20M | $21M | $30M | $24M | |
| Investing Cash Flow | $-40M | $17M | $172M | $211M | $-246M | $-253M | |
| Stock Issued | $126M | $181M | $27M | $4M | $5M | · | |
| Net Stock Activity | $126M | · | $5M | $601.0K | · | · | |
| Financing Cash Flow | $129M | $200M | $32M | $5M | $632M | $436M | |
| Net Change in Cash | $-55M | $-6M | $-50M | $-75M | $135M | $45M | |
| Free Cash Flow | $-145M | $-257M | $-274M | $-311M | $-281M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -53.2% | -50.0% | -40.8% | -27.6% | -38.3% | · | |
| ROE | -172.3% | -98.3% | -86.7% | -50.6% | -45.7% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 3.5 | 3.3 | 4.0 | 5.6 | · | |
| Quick Ratio | 1.8 | 3.4 | 3.2 | 3.8 | 5.6 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.60 | $1.12 | $1.45 | $2.61 | $3.94 | · | |
| Cash Flow / Share | $-0.57 | $-0.97 | $-1.30 | $-1.54 | · | · | |
| Cash / Share | $0.27 | $0.57 | $0.67 | $0.93 | $1.37 | · | |
| EPS (TTM) | $-0.96 | $-1.16 | $-1.46 | $-1.43 | $-2.14 | $-21.92 |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-244M | $-267M | $-283M | $-269M | $-356M | $-285M | |
| Market Cap | $1.09B | $365M | $807M | $755M | $2.86B | · | |
| P/E | -4.2 | -1.4 | -2.8 | -2.8 | -7.2 | · | |
| P/B | 6.7 | 1.5 | 2.8 | 1.5 | 3.9 | · | |
| P / Tangible Book | · | 7.2 | 9.2 | 2.5 | 5.4 | · | |
| P / Cash Flow | -7.5 | -1.6 | -3.2 | -2.6 | -11.4 | · | |
| P / FCF | -7.5 | -1.4 | -3.0 | -2.4 | -10.2 | · | |
| Earnings Yield | -23.6% | -71.2% | -35.8% | -36.2% | -13.8% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $31M | $29M | $35M | $30M | $30M | $37M | $45M | $53M | $61M | $56M | $66M | $73M | $67M | $77M | $73M | $73M | |
| SG&A Expense | $11M | $11M | $12M | $10M | $10M | $11M | $17M | $14M | $16M | $16M | $19M | $17M | $17M | $16M | $18M | $14M | |
| Operating Expenses | $65M | $49M | $61M | $44M | $95M | $51M | $51M | $62M | $49M | $111M | $2M | $116M | $84M | $86M | $73M | $32M | |
| Operating Income | $-65M | $-49M | $-61M | $-44M | $-95M | $-51M | $-51M | $-62M | $-49M | $-111M | $-2M | $-116M | $-84M | $-86M | $-73M | $-32M | |
| Other Non-op | $656.0K | $453.0K | $1M | $360.0K | $598.0K | $249.0K | $141.0K | $-742.0K | $-4M | $215.0K | $303.0K | $-84.0K | $-47.0K | $-106.0K | $-198.0K | $-102.0K | |
| Net Income | $-64M | $-47M | $-59M | $-42M | $-94M | $-49M | $-49M | $-60M | $-50M | $-107M | $984.0K | $-114M | $-82M | $-85M | $-72M | $-31M | |
| EPS (Basic) | $-0.22 | $-0.17 | $-0.20 | $-0.16 | $-0.39 | $-0.21 | $-0.21 | $-0.25 | $-0.21 | $-0.49 | $0.00 | $-0.59 | $-0.43 | $-0.45 | $-0.39 | $-0.17 | |
| EPS (Diluted) | $-0.22 | $-0.17 | $-0.20 | $-0.16 | $-0.39 | $-0.21 | $-0.21 | $-0.25 | $-0.21 | $-0.49 | $0.00 | $-0.59 | $-0.43 | $-0.45 | $-0.39 | $-0.17 | |
| Shares (Basic) | 295,667,000 | 276,856,000 | · | 260,494,000 | 238,409,000 | 237,578,000 | · | 235,412,000 | 234,440,000 | 217,290,000 | 196,978,000 | 192,540,000 | 191,228,000 | 189,303,000 | 187,626,000 | 185,955,000 | |
| Shares (Diluted) | 295,667,000 | 276,856,000 | · | 260,494,000 | 238,409,000 | 237,578,000 | · | 235,412,000 | 234,440,000 | 217,290,000 | 200,473,000 | 192,540,000 | 191,228,000 | 189,303,000 | 187,626,000 | 185,955,000 | |
| EBITDA | · | $-49M | · | $-44M | $-95M | $-51M | · | $-62M | $-49M | $-111M | $-2M | $-116M | $-84M | $-86M | $-73M | $-32M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $57M | $84M | $72M | $103M | $71M | $96M | $128M | $127M | $135M | $177M | $168M | $174M | $160M | $163M | $195M | $189M | |
| Short-term Investments | $103M | $17M | $67M | $50M | $1M | $9M | $25M | $72M | $117M | $134M | $100M | $152M | $189M | $322M | $290M | $324M | |
| Prepaid Expense | $6M | $6M | $6M | $5M | $6M | $4M | $4M | $7M | $8M | $6M | $7M | $7M | $15M | $8M | $10M | $11M | |
| Current Assets | $171M | $112M | $149M | $162M | $83M | $113M | $161M | $210M | $263M | $321M | $280M | $339M | $370M | $500M | $494M | $523M | |
| PP&E (Net) | $25M | $26M | $27M | $30M | $33M | $74M | $77M | $83M | $86M | $82M | $68M | $63M | $64M | $67M | $68M | $69M | |
| PP&E (Gross) | $85M | $83M | $82M | $84M | $86M | $131M | $131M | $136M | $135M | $127M | $116M | $105M | $103M | $98M | $94M | $91M | |
| Accum. Depreciation | $59M | $57M | $55M | $54M | $53M | $57M | $54M | $53M | $49M | $46M | $47M | $43M | $38M | $30M | $26M | $22M | |
| Goodwill | $141M | $141M | $141M | $141M | $141M | $141M | $141M | $141M | $141M | $141M | $141M | $141M | $141M | $141M | $141M | $141M | |
| Intangibles | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | |
| Other Non-current Assets | $552.0K | $563.0K | $3M | $3M | $3M | $4M | $5M | $6M | $6M | $7M | $6M | $7M | $5M | $5M | $5M | $5M | |
| Total Assets | $432M | $374M | $417M | $435M | $362M | $445M | $501M | $559M | $619M | $681M | $631M | $707M | $747M | $898M | $971M | $1.05B | |
| Accounts Payable | $1M | $2M | $2M | $2M | $2M | $989.0K | $5M | $3M | $4M | $6M | $10M | $3M | $2M | $4M | $3M | $5M | |
| Current Liabilities | $124M | $86M | $79M | $36M | $33M | $33M | $45M | $47M | $51M | $53M | $67M | $112M | $103M | $115M | $97M | $94M | |
| Capital Leases | $59M | $60M | $64M | $68M | $72M | $78M | $82M | $85M | $89M | $93M | $83M | $100M | $102M | $100M | $103M | $103M | |
| Other Non-current Liabilities | $9M | $10M | $11M | $8M | $8M | $9M | $10M | $7M | $7M | · | · | · | · | · | · | · | |
| Total Liabilities | $277M | $254M | $256M | $240M | $239M | $236M | $251M | $267M | $279M | $306M | $266M | $352M | $319M | $332M | $332M | $346M | |
| Common Stock | $30.0K | $27.0K | $27.0K | $26.0K | $23.0K | $23.0K | $22.0K | $22.0K | $22.0K | $22.0K | $20.0K | $20.0K | $19.0K | $19.0K | $19.0K | $19.0K | |
| Paid-in Capital | $2.11B | $2.02B | $2.01B | $1.99B | $1.87B | $1.86B | $1.86B | $1.85B | $1.84B | $1.82B | $1.62B | $1.61B | $1.57B | $1.55B | $1.54B | $1.52B | |
| Retained Earnings | $-1.96B | $-1.90B | $-1.85B | $-1.79B | $-1.75B | $-1.65B | $-1.60B | $-1.56B | $-1.50B | $-1.45B | $-1.25B | $-1.25B | $-1.14B | $-974M | $-889M | $-817M | |
| AOCI | $-66.0K | $-2.0K | $28.0K | $21.0K | $0 | $0 | $14.0K | $54.0K | $-19.0K | $-15.0K | $-202.0K | $-865.0K | $-2M | $-6M | $-6M | $-5M | |
| Stockholders' Equity | $155M | $119M | $161M | $195M | $123M | $209M | $251M | $292M | $340M | $375M | $366M | $355M | $428M | $566M | $640M | $702M | |
| Liabilities + Equity | $432M | $374M | $417M | $435M | $362M | $445M | $501M | $559M | $619M | $681M | $631M | $707M | $747M | $898M | $971M | $1.05B | |
| Shares Outstanding | 299,306,000 | 269,817,000 | 266,732,000 | 262,264,000 | 230,510,000 | 225,463,000 | 223,923,000 | 223,108,000 | 222,209,000 | 221,286,000 | 197,064,000 | 196,880,000 | 191,409,000 | 189,885,000 | 188,430,000 | 186,632,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $6M | $6M | $5M | $7M | $7M | $6M | $11M | $11M | $9M | $9M | $10M | $9M | $10M | $10M | $8M | |
| Operating Cash Flow | $-33M | $-37M | $-33M | $-29M | $-33M | $-49M | $-47M | $-52M | $-59M | $-66M | $-64M | $-59M | $-79M | $-65M | $-71M | $-78M | |
| CapEx | $2M | $288.0K | $873.0K | $41.0K | $-112.0K | $136.0K | $436.0K | $4M | $13M | $16M | $2M | $2M | $2M | $4M | $4M | $8M | |
| Investing Cash Flow | $-88M | $49M | $-16M | $-48M | $8M | $17M | $47M | $42M | $6M | $-77M | $51M | $43M | $63M | $32M | $78M | $13M | |
| Stock Issued | · | · | $17M | $109M | · | · | $0 | $-29.0K | · | · | $192.0K | $2M | $236.0K | $897.0K | $2M | $652.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | $236.0K | · | · | · | |
| Financing Cash Flow | $94M | $-128.0K | $18M | $110M | $561.0K | $982.0K | $643.0K | $2M | $11M | $186M | $187.0K | $30M | $236.0K | $2M | $2M | $652.0K | |
| Net Change in Cash | $-27M | $12M | $-31M | $32M | $-25M | $-31M | $570.0K | $-8M | $-42M | $44M | $-12M | $13M | $-16M | $-31M | $8M | $-65M | |
| Free Cash Flow | · | $-38M | · | · | · | $-49M | · | · | · | $-81M | · | · | $-81M | · | · | $-85M |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | -11.5% | · | -8.5% | -19.1% | -8.8% | · | -10.1% | -7.6% | -15.0% | 0.13% | -13.6% | -9.2% | -8.0% | -6.5% | -2.7% | |
| ROE | · | -28.8% | · | -17.3% | -40.6% | -16.9% | · | -18.2% | -14.5% | -26.8% | 0.21% | -22.9% | -14.5% | -12.2% | -9.4% | -4.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 1.3 | · | 4.6 | 2.5 | 3.4 | · | 4.5 | 5.2 | 6.1 | 4.2 | 3.0 | 3.6 | 4.4 | 5.1 | 5.6 | |
| Quick Ratio | · | 1.2 | · | 4.3 | 2.2 | 3.2 | · | 4.2 | 5.0 | 5.9 | 4.0 | 2.9 | 3.4 | 4.2 | 5.0 | 5.5 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $0.44 | · | $0.74 | $0.53 | $0.93 | · | $1.31 | $1.53 | $1.70 | $1.86 | $1.80 | $2.24 | $2.98 | $3.39 | $3.76 | |
| Cash Flow / Share | · | $-0.14 | · | · | · | $-0.20 | · | · | · | $-0.30 | · | · | $-0.41 | · | · | · | |
| Cash / Share | · | $0.31 | · | $0.39 | $0.31 | $0.43 | · | $0.57 | $0.61 | $0.80 | $0.85 | $0.88 | $0.84 | $0.86 | $1.03 | $1.01 | |
| EPS (TTM) | $-0.94 | $-0.92 | · | $-0.97 | $-1.06 | $-0.88 | · | $-1.39 | $-1.14 | $-1.52 | $-1.44 | $-1.89 | $-1.69 | $-1.62 | $-1.63 | $-1.15 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-212M | $-242M | · | $-234M | $-252M | $-209M | · | $-306M | $-245M | $-309M | $-276M | $-362M | $-320M | $-300M | $-298M | $-207M | |
| Market Cap | · | $777M | · | $931M | $629M | $379M | · | $928M | $1.21B | $2.21B | $763M | $1.17B | $626M | $1.14B | $1.21B | $1.54B | |
| P/E | -3.7 | -3.1 | · | -3.7 | -2.6 | -1.9 | · | -3.0 | -4.8 | -6.6 | -2.7 | -3.2 | -1.9 | -3.7 | -3.9 | -7.2 | |
| P/B | · | 6.5 | · | 4.8 | 5.1 | 1.8 | · | 3.2 | 3.6 | 5.9 | 2.1 | 3.3 | 1.5 | 2.0 | 1.9 | 2.2 | |
| P / Tangible Book | · | · | · | · | · | 40.9 | · | 10.0 | 8.7 | 12.6 | 4.6 | 7.6 | 2.7 | 3.1 | 2.8 | 3.1 | |
| P / Cash Flow | · | -20.8 | · | · | · | -7.8 | · | · | · | -33.7 | · | · | -7.9 | · | · | -19.8 | |
| Earnings Yield | -26.9% | -31.9% | · | -27.3% | -38.8% | -52.4% | · | -33.4% | -20.9% | -15.2% | -37.2% | -31.7% | -51.7% | -27.0% | -25.4% | -13.9% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Nettoergebnis | $-244M | $-267M | $-283M | $-269M | $-356M |
| Verwässerte EPS | $-0.96 | $-1.16 | $-1.46 | $-1.43 | $-2.14 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 1.9 | 3.5 | 3.3 | 4.0 | 5.6 |
| Quick Ratio | 1.8 | 3.4 | 3.2 | 3.8 | 5.6 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-145M | $-257M | $-274M | $-311M | $-281M |
Institutionelle Eigentümer (13F) 228 Einreicher · $688.7M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
228
Gehaltener Wert
$688.7M
Neue Positionen
33
Geschlossene Positionen
21
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 33 (+1 vs. Vorquartal) | 21 (-2 vs. Vorquartal) | 68 (0 vs. Vorquartal) | 66 (+8 vs. Vorquartal) | +20.8M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $130.629.007 | 37.429.515 | 18,97% | Aktien |
| Flagship Pioneering, LLC | $87.256.477 | 25.001.856 | 12,67% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $65.437.500 | 18.750.000 | 9,50% | Aktien |
| BlackRock, Inc. | $58.196.354 | 16.675.173 | 8,45% | Aktien |
| VANGUARD GROUP INC | $42.552.645 | 10.455.195 | 6,18% | Aktien |
| STATE STREET CORP | $39.098.938 | 11.203.134 | 5,68% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $35.662.216 | 10.218.400 | 5,18% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $29.230.219 | 8.375.421 | 4,24% | Aktien |
| BANK OF AMERICA CORP /DE/ | $20.062.105 | 5.748.454 | 2,91% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $16.329.082 | 4.677.959 | 2,37% | Aktien |
| Marex Group Ltd | $13.921.959 | 3.989.100 | 2,02% | Aktien |
| MARSHALL WACE, LLP | $10.230.711 | 2.931.436 | 1,49% | Aktien |
| Alphabet Inc. | $9.815.625 | 2.812.500 | 1,43% | Aktien |
| GOLDMAN SACHS GROUP INC | $8.264.094 | 2.367.935 | 1,20% | Aktien |
| Integral Health Asset Management, LLC | $6.980.000 | 2.000.000 | 1,01% | Aktien |
| TORONTO DOMINION BANK | $6.883.610 | 1.972.381 | 1,00% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6.567.095 | 1.881.689 | 0,95% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $6.521.826 | 1.868.718 | 0,95% | Aktien |
| NORTHERN TRUST CORP | $5.598.252 | 1.604.084 | 0,81% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4.813.342 | 1.379.181 | 0,70% | Aktien |
| Woodline Partners LP | $4.599.583 | 1.317.932 | 0,67% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $4.318.655 | 1.237.437 | 0,63% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $4.296.539 | 1.231.100 | 0,62% | Aktien |
| MORGAN STANLEY | $3.977.839 | 1.139.782 | 0,58% | Aktien |
| UBS Group AG | $3.704.429 | 1.061.441 | 0,54% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $3.361.383 | 963.147 | 0,49% | Aktien |
| Omega Fund Management, LLC | $2.944.688 | 843.750 | 0,43% | Aktien |
| JPMORGAN CHASE & CO | $2.681.678 | 777.298 | 0,39% | Aktien |
| Crestline Management, L.P. | $2.637.619 | 755.736 | 0,38% | Aktien |
| ArrowMark Colorado Holdings LLC | $2.391.086 | 685.125 | 0,35% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $2.280.725 | 653.503 | 0,33% | Aktien |
| DEUTSCHE BANK AG\ | $2.251.353 | 645.087 | 0,33% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $2.229.541 | 638.837 | 0,32% | Aktien |
| Corient Private Wealth LP | $2.192.069 | 628.100 | 0,32% | Aktien |
| Point72 Asset Management, L.P. | $2.076.868 | 595.091 | 0,30% | Aktien |
| Invesco Ltd. | $1.759.875 | 504.262 | 0,26% | Aktien |
| Bank of New York Mellon Corp | $1.666.621 | 477.542 | 0,24% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.340.450 | 384.083 | 0,19% | Aktien |
| Nuveen, LLC | $1.290.329 | 369.722 | 0,19% | Aktien |
| Swiss National Bank | $1.214.869 | 348.100 | 0,18% | Aktien |
| BAKER BROS. ADVISORS LP | $1.083.586 | 310.483 | 0,16% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $1.028.998 | 294.842 | 0,15% | Aktien |
| CITIGROUP INC | $951.109 | 272.524 | 0,14% | Aktien |
| TWO SIGMA ADVISERS, LP | $902.201 | 221.671 | 0,13% | Aktien |
| XTX Topco Ltd | $790.799 | 226.590 | 0,11% | Aktien |
| RHUMBLINE ADVISERS | $779.695 | 223.412 | 0,11% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $694.510 | 199.000 | 0,10% | Kaufoption |
| Rafferty Asset Management, LLC | $686.591 | 196.731 | 0,10% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $674.557 | 193.283 | 0,10% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $667.313 | 231.706 | 0,10% | Aktien |
Unternehmensinsider 22 Insider · 10 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Steve Harr | President & CEO | 7. März 2026 M | 7.944.251 | 0 | 0 | $0 |
| Brian Piper | EVP, Chief Financial Officer | 17. Februar 2026 A | · | 0 | 0 | $0 |
| Nathan Hardy | EVP, Chief Financial Officer | 7. März 2024 A | · | 0 | 0 | $0 |
| Dhavalkumar Dhirajlal Patel | EVP, Chief Scientific Officer | 26. August 2026 M | 183.352 | 0 | 0 | $0 |
| Susan D. Wyrick | SVP, Finance and Accounting and Principal Accounting Officer | 7. März 2026 M | 196.196 | 0 | 0 | $0 |
| Bernard J Cassidy | EVP & General Counsel | 7. März 2025 M | 112.990 | 0 | 0 | $0 |
| Christian Hordo | EVP, Chief Business Officer | 7. März 2024 A | 867.455 | 0 | 0 | $0 |
| Douglas E Williams | EVP & President, R&D | 7. März 2024 A | · | 0 | 0 | $0 |
| James J. Macdonald | EVP & General Counsel | 13. Juni 2022 M | 497.396 | 0 | 0 | $0 |
| Sunil Agarwal | EVP, Head of Development & CMO | 3. März 2022 A | 1.550.000 | 0 | 0 | $0 |
| Hans Edgar Bishop | Direktor | 6. Juli 2026 A | 5.854.800 | 0 | 0 | $0 |
| Michelle Seitz | Direktor | 4. Juni 2026 A | · | 0 | 0 | $0 |
| Alise Reicin | Direktor | 4. Juni 2026 A | · | 0 | 0 | $0 |
| Robert L. Rosiello | Direktor | 4. Juni 2026 A | · | 0 | 0 | $0 |
| Joshua H. Bilenker | Direktor | 4. Juni 2026 A | 20.000 | 0 | 0 | $0 |
| Richard Mulligan | Direktor | 4. Juni 2026 A | 2.698.121 | 0 | 0 | $0 |
| Patrick Y Yang | Direktor | 4. Juni 2026 A | 149.250 | 0 | 0 | $0 |
| Robert Nelsen | Direktor | 4. Juni 2026 A | 12.446.022 | 0 | 0 | $0 |
| Mary Agnes Wilderotter | Direktor | 5. Juni 2025 A | 7.106 | 0 | 0 | $0 |
| Douglas G. Cole | Direktor | 6. Juni 2024 A | · | 0 | 0 | $0 |
| Geoffrey Von Maltzahn | Direktor | 3. Februar 2021 A | 366.122 | 0 | 0 | $0 |
| FMR LLC | 10%-Eigentümer | 8. Januar 2025 S | 4.541.511 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 26 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,78% | 115.976 NS | 31. Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,15% | 240.493 NS | 31. Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,06% | 21.172 SH | 2. Oktober 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,04% | 3.286 NS | 31. Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 384.433 SH | 2. Oktober 2026 | Täglich |
| IBB · iShares Trust | 0,04% | 1.388.372 SH | 11. September 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,04% | 196.803 SH | 19. August 2026 | Täglich |
| IWO · iShares Trust | 0,04% | 1.718.279 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 1.056.163 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,02% | 4.720.089 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,02% | 87.720 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1.941.879 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 521.984 SH | 19. August 2026 | Täglich |
| ISCG · iShares Trust | 0,01% | 28.058 SH | 11. September 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 80.330 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,00% | 10.383 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,00% | 22.436 NS | 31. Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 110.952 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 256.132 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 50.195 SH | 9. September 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,00% | 12.291 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 6.251.644 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 13.302 SH | 19. August 2026 | Täglich |
| ISCB · iShares Trust | · | 8.018 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 21.821 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 429.504 SH | 11. September 2026 | Täglich |
SANA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 15 Analysten
KAUF
Median-Ziel
$7.00
+142,2%
6 40,0%
Starker Kauf
7 46,7%
Kauf
2 13,3%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
7 Analysten · 2026-09-30Mittelwert-Ziel $8.43 +191,6%
← Unter allen Zielen
Aktueller Preis $2.89
Tief$6.00
Mittelwert$8.43
Hoch$12.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| SANA | $1.09B | -4.2 | · | · | -172.3% | · |
| CRVS | $575M | -14.5 | · | · | -21.6% | · |
| JBIO | $761M | -4.8 | · | · | -47.7% | · |
| GLUE | $1.03B | · | 63.5% | -31.2% | -15.4% | · |
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | · |
| OBX | · | · | · | · | · | · |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | · |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | · |
| ANNX | $750M | -3.7 | · | · | -100.7% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 10, 2026